Cargando…
Design, development and permeation studies of nebivolol hydrochloride from novel matrix type transdermal patches
BACKGROUND: Nebivolol hydrochloride is a third generation β-blocker with highly selective β(1)-receptor antagonist with antihypertensive properties having plasma half life of 10 h and 12% oral bioavailability. The aim of the present investigation was to form matrix type transdermal patches containin...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814574/ https://www.ncbi.nlm.nih.gov/pubmed/24223377 http://dx.doi.org/10.4103/2277-9175.115813 |